HomeFOLD • NASDAQ
add
Amicus Therapeutics, Inc.
Previous close
$9.85
Day range
$9.74 - $9.97
Year range
$5.51 - $10.57
Market cap
3.05B USD
Avg Volume
4.97M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 169.06M | 19.46% |
Operating expense | 115.32M | 11.49% |
Net income | 17.31M | 357.19% |
Net profit margin | 10.24 | 315.58% |
Earnings per share | 0.17 | 70.00% |
EBITDA | 36.14M | 34.00% |
Effective tax rate | 49.51% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 263.84M | 5.64% |
Total assets | 868.81M | 10.46% |
Total liabilities | 638.39M | 5.04% |
Total equity | 230.42M | — |
Shares outstanding | 308.53M | — |
Price to book | 13.13 | — |
Return on assets | 10.17% | — |
Return on capital | 12.97% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 17.31M | 357.19% |
Cash from operations | 35.66M | 255.24% |
Cash from investing | -1.30M | -103.79% |
Cash from financing | -1.32M | -107.25% |
Net change in cash | 31.84M | 30.16% |
Free cash flow | 42.35M | 247.11% |
About
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, PA. The company went public in 2007 under the NASDAQ trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. Wikipedia
Founded
Feb 4, 2002
Website
Employees
499
